BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2437 related articles for article (PubMed ID: 15837366)

  • 1. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunisation of fancy chickens against Newcastle disease].
    Freund I; Dzapo V; Vielitz E; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Oct; 108(10):414-8. PubMed ID: 11721588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of breeder vaccination on immunization of progeny against Newcastle disease.
    Giambrone JJ; Closser J
    Avian Dis; 1990; 34(1):114-9. PubMed ID: 2322221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
    Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
    Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
    Folitse R; Halvorson DA; Sivanandan V
    Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory evaluation of Newcastle disease vaccination programs for broiler chickens.
    Giambrone JJ
    Avian Dis; 1985; 29(2):479-87. PubMed ID: 4026739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of live Newcastle disease vaccines in a simple vaccination and challenge experiment.
    Voeten AC; Orthel FW; Jacobs J
    Res Vet Sci; 1977 Mar; 22(2):138-45. PubMed ID: 870956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of vaccinated slaughter ostriches in a natural, open-air feedlot facility with virulent Newcastle disease virus.
    Verwoerd DJ; Olivier A; Gummow B; Gerdes GH; Williams R
    Avian Dis; 1999; 43(3):442-52. PubMed ID: 10494412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Newcastle disease by vaccination.
    Senne DA; King DJ; Kapczynski DR
    Dev Biol (Basel); 2004; 119():165-70. PubMed ID: 15742628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease.
    Ahmad J; Sharma JM
    Am J Vet Res; 1992 Nov; 53(11):1999-2004. PubMed ID: 1466491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.